Gene test may forecast sepsis survival

NCT ID NCT07533994

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study explored whether measuring the activity of a gene called Acod1 in blood cells can help predict which sepsis patients are at higher risk of dying. Researchers enrolled 52 adults in the ICU and measured Acod1 levels within 48 hours of admission. The goal was to see if this gene could serve as a new tool for early risk assessment, alongside standard scores like SOFA and APACHE II.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Critical Care Medicine, Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan

    Wuhan, Hubei, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China